If you have Adobe Reader installed please click here to read the full PDF of approved uses for Cabergoline (Dostinex).

Description:

Cabergoline increases the levels of dopamine through its action of stimulating D2 receptor sites, it is officially approved to assist in the treatment of Parkinson’s disease, as well as treat states of prolactinoma (i.e. prevent breast development in men and reduce excess milk secretion in women).

Directions:

Take 0.25mg or 0.5mg no more than twice per week, unless treating a serious medical disorder whereupon the dosage may differ according to your physician's guidance, usually built up slowly to no more than 1mg twice weekly.

Disclaimer:

This product and its statements have not been evaluated by the FDA. This product is not intended to treat, cure or prevent any disease.

Supplement facts:

Each tablet contains 0.5mg Cabergoline.

Note:

Keep out of reach of children. Not for use by pregnant or lactating women.

The above information is the translation of the manufacturer's insert. It is provided under the supplying company's terms and conditions and should not replace the advice of your personal physician.